These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 20206289)

  • 21. Physicochemical Modifications and Nano Particulate Strategies for Improved Bioavailability of Poorly Water Soluble Drugs.
    Siddiqui K; Waris A; Akber H; Munir K; Mir M; Khan MW; Aman W; Fakhar-Ud-Din
    Pharm Nanotechnol; 2017; 5(4):276-284. PubMed ID: 29278217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs.
    Mahmood T; Sarfraz RM; Ismail A; Ali M; Khan AR
    Assay Drug Dev Technol; 2023; 21(2):65-79. PubMed ID: 36917562
    [No Abstract]   [Full Text] [Related]  

  • 23. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.
    Kawakami K
    Adv Drug Deliv Rev; 2012 May; 64(6):480-95. PubMed ID: 22265844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in the study of drug nanocrystals.
    Shi J; Guo F; Zheng A; Zhang X; Sun J
    Pharmazie; 2015 Dec; 70(12):757-64. PubMed ID: 26817271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.
    Chiappetta DA; Sosnik A
    Eur J Pharm Biopharm; 2007 Jun; 66(3):303-17. PubMed ID: 17481869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micellar solubilization of drugs.
    Rangel-Yagui CO; Pessoa A; Tavares LC
    J Pharm Pharm Sci; 2005 Jul; 8(2):147-65. PubMed ID: 16124926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of polymeric nanostructure shape on drug delivery.
    Venkataraman S; Hedrick JL; Ong ZY; Yang C; Ee PL; Hammond PT; Yang YY
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1228-46. PubMed ID: 21777633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted polymeric micelles for delivery of poorly soluble drugs.
    Torchilin VP
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2549-59. PubMed ID: 15526161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.
    Thakkar S; Shah V; Misra M; Kalia K
    Recent Pat Nanotechnol; 2017 Jul; 11(2):130-145. PubMed ID: 27758683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
    Kiriyama A; Iga K; Shibata N
    Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM; Griffin BT
    Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery.
    Brough C; Williams RO
    Int J Pharm; 2013 Aug; 453(1):157-66. PubMed ID: 23751341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances and patents in solid dispersion technology.
    Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of injectable drug nanocrystals.
    Fuhrmann K; Gauthier MA; Leroux JC
    Mol Pharm; 2014 Jun; 11(6):1762-71. PubMed ID: 24766270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-solubilization of poorly soluble drugs by micellization and complexation.
    Rao VM; Nerurkar M; Pinnamaneni S; Rinaldi F; Raghavan K
    Int J Pharm; 2006 Aug; 319(1-2):98-106. PubMed ID: 16765542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
    Lukyanov AN; Torchilin VP
    Adv Drug Deliv Rev; 2004 May; 56(9):1273-89. PubMed ID: 15109769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals - A comprehensive review.
    Padrela L; Rodrigues MA; Duarte A; Dias AMA; Braga MEM; de Sousa HC
    Adv Drug Deliv Rev; 2018 Jun; 131():22-78. PubMed ID: 30026127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs.
    Sezgin Z; Yüksel N; Baykara T
    Eur J Pharm Biopharm; 2006 Nov; 64(3):261-8. PubMed ID: 16884896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.